GLP-1s (Glucagon-Like Peptide-1 receptor agonists) are a class of medications originally developed to help manage type 2 diabetes
doi: 10.1016/j.pharmthera.2011.01.014
DOI: 10.1530/eje.0.1390552 Ankersen M, Johansen NL, Madsen K, Hansen BS, Raun K, Nielsen KK, et al
Key antioxidant enzymes, such as glutathione peroxidase (GPX1), glutathione reductase (GSR), superoxide dismutase (SOD1 and SOD2), and members of the thioredoxin family, exhibit reduced expression in oocytes from aged animals
Supplementation with gamma-glutamylcysteine has been demonstrated in a human clinical trial to increase cellular glutathione levels regardless of its initial (basal) concentration